All changes for the tissue kidney (130)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA290
lysozyme (renal amyloidosis)
Molecular
kidney
Human
LYZ
57.0% Increase Gene Expression Level
DAA266
matrix metallopeptidase 7 (matrilysin, uterine)
Molecular
kidney
Human
MMP7
23.0% Increase Gene Expression Level
DAA2026
Mutations in mitochondrial DNA accumulate
Physiological
heart, kidney, skeletal muscle, cerebral cortex, cerebellum
Human
—
—
DAA279
nicotinamide N-methyltransferase
Molecular
kidney
Human
NNMT
40.0% Increase Gene Expression Level
DAA264
paraoxonase 3
Molecular
kidney
Human
PON3
13.0% Decrease Gene Expression Level
DAA278
Ras-related GTP binding D
Molecular
kidney
Human
RRAGD
14.0% Decrease Gene Expression Level
DAA2020
Reduction in renal function
Physiological
kidney
Human
—
—
DAA640
Renal failure
Pathological
kidney
Human
—
SeriesMorbidity
DAA276
Rh family, C glycoprotein
Molecular
kidney
Human
RHCG
16.0% Decrease Gene Expression Level
DAA282
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
Molecular
kidney
Human
SERPINA5
11.0% Decrease Gene Expression Level
DAA902
specific activities of enzymes are reduced
Molecular
kidney
Human
—
—
DAA268
solute carrier family 12 (sodium/chloride transporters), member 3
Molecular
kidney
Human
SLC12A3
16.0% Decrease Gene Expression Level
DAA286
StAR-related lipid transfer (START) domain containing 8
Molecular
kidney
Human
STARD8
14.0% Decrease Gene Expression Level
DAA901
telomere shortening
Molecular
kidney
Human
—
—
DAA277
tyrosinase-related protein 1
Molecular
kidney
Human
TYRP1
21.0% Decrease Gene Expression Level
DAA1498
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1
Molecular
kidney
Mouse
Hmgcs1
4.0% Decrease Gene Expression Level
DAA1489
acyl-CoA synthetase medium-chain family member 2
Molecular
kidney
Mouse
Acsm2
5.0% Decrease Gene Expression Level
DAA1485
acylphosphatase 2, muscle type
Molecular
kidney
Mouse
Acyp2
7.0% Decrease Gene Expression Level
DAA1475
a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1
Molecular
kidney
Mouse
Adamts1
7.0% Increase Gene Expression Level
DAA1467
annexin A2
Molecular
kidney
Mouse
Anxa2
8.0% Increase Gene Expression Level
DAA1464
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1
Molecular
kidney
Mouse
Atp5f1
5.0% Decrease Gene Expression Level
DAA1477
biglycan
Molecular
kidney
Mouse
Bgn
10.0% Increase Gene Expression Level
DAA1458
brevican
Molecular
kidney
Mouse
Bcan
6.0% Decrease Gene Expression Level
DAA1444
cathepsin S
Molecular
kidney
Mouse
Ctss
17.0% Increase Gene Expression Level
DAA1447
CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)
Molecular
kidney
Mouse
Cd74
14.0% Increase Gene Expression Level
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA290 | lysozyme (renal amyloidosis) | Molecular | kidney | Human | LYZ | 57.0% Increase Gene Expression Level | |
DAA266 | matrix metallopeptidase 7 (matrilysin, uterine) | Molecular | kidney | Human | MMP7 | 23.0% Increase Gene Expression Level | |
DAA2026 | Mutations in mitochondrial DNA accumulate | Physiological | heart, kidney, skeletal muscle, cerebral cortex, cerebellum | Human | — | — | |
DAA279 | nicotinamide N-methyltransferase | Molecular | kidney | Human | NNMT | 40.0% Increase Gene Expression Level | |
DAA264 | paraoxonase 3 | Molecular | kidney | Human | PON3 | 13.0% Decrease Gene Expression Level | |
DAA278 | Ras-related GTP binding D | Molecular | kidney | Human | RRAGD | 14.0% Decrease Gene Expression Level | |
DAA2020 | Reduction in renal function | Physiological | kidney | Human | — | — | |
DAA640 | Renal failure | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA276 | Rh family, C glycoprotein | Molecular | kidney | Human | RHCG | 16.0% Decrease Gene Expression Level | |
DAA282 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Molecular | kidney | Human | SERPINA5 | 11.0% Decrease Gene Expression Level | |
DAA902 | specific activities of enzymes are reduced | Molecular | kidney | Human | — | — | |
DAA268 | solute carrier family 12 (sodium/chloride transporters), member 3 | Molecular | kidney | Human | SLC12A3 | 16.0% Decrease Gene Expression Level | |
DAA286 | StAR-related lipid transfer (START) domain containing 8 | Molecular | kidney | Human | STARD8 | 14.0% Decrease Gene Expression Level | |
DAA901 | telomere shortening | Molecular | kidney | Human | — | — | |
DAA277 | tyrosinase-related protein 1 | Molecular | kidney | Human | TYRP1 | 21.0% Decrease Gene Expression Level | |
DAA1498 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 | Molecular | kidney | Mouse | Hmgcs1 | 4.0% Decrease Gene Expression Level | |
DAA1489 | acyl-CoA synthetase medium-chain family member 2 | Molecular | kidney | Mouse | Acsm2 | 5.0% Decrease Gene Expression Level | |
DAA1485 | acylphosphatase 2, muscle type | Molecular | kidney | Mouse | Acyp2 | 7.0% Decrease Gene Expression Level | |
DAA1475 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 | Molecular | kidney | Mouse | Adamts1 | 7.0% Increase Gene Expression Level | |
DAA1467 | annexin A2 | Molecular | kidney | Mouse | Anxa2 | 8.0% Increase Gene Expression Level | |
DAA1464 | ATP synthase, H+ transporting, mitochondrial F0 complex, subunit b, isoform 1 | Molecular | kidney | Mouse | Atp5f1 | 5.0% Decrease Gene Expression Level | |
DAA1477 | biglycan | Molecular | kidney | Mouse | Bgn | 10.0% Increase Gene Expression Level | |
DAA1458 | brevican | Molecular | kidney | Mouse | Bcan | 6.0% Decrease Gene Expression Level | |
DAA1444 | cathepsin S | Molecular | kidney | Mouse | Ctss | 17.0% Increase Gene Expression Level | |
DAA1447 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | Molecular | kidney | Mouse | Cd74 | 14.0% Increase Gene Expression Level |